Phase 1 Safety and PK Study of OLT1177 Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

OLT1177 Capsules

OLT1177 Capsules are an experimental drug.

DRUG

Placebo Capsules

Placebo Capsules are identical in all ways to the study drug, but contain no active pharmaceutical ingredient.

Trial Locations (1)

77845

J&S Studies, Inc, College Station

Sponsors
All Listed Sponsors
lead

Olatec Therapeutics LLC

INDUSTRY

NCT02134964 - Phase 1 Safety and PK Study of OLT1177 Capsules | Biotech Hunter | Biotech Hunter